Chaitanya Harita: Presenting AML Research at the British Society for Haematology Annual Scientific Meeting 2026
Chaitanya Harita, Assistant Professor and Consultant – Clinical Haematology, Haemato Oncology and Bone Marrow Transplant at St. John’s National Academy of Health Sciences, shared a post on LinkedIn:
“Attended The British Society for Haematology Annual Scientific Meeting in Liverpool in April this year – an extremely rewarding and enriching professional experience.
I was privileged to present two of our original works:
- Induction outcomes in newly diagnosed AML – intensive versus lower-intensity therapy: a single-centre experience.
This work focused on how azacitidine-venetoclax-based approaches are reshaping induction outcomes in newly diagnosed AML, with meaningful responses seen across risk stratification groups. - The molecular biology of acute myeloid leukemia in the Indian context
This work explored how Indian AML patients appear biologically a decade older despite being chronologically younger than their Western counterparts, and how next-generation sequencing at diagnosis is driving a major paradigm shift in AML risk stratification.
Both posters were very well received, and beyond the academic discussions, what made the experience special was the opportunity to meet, learn from, and interact with colleagues from across the world.
Attending the conference was both humbling and inspiring, and it has only strengthened my passion for clinical hematology and research.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question